(R)-tert-Butyl 3-(2-amino-4-fluorophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

1-Acetylpyrrolidine-2-carboxylic acid, 95.0%, 5g

Ethyl cyclopropanecarbimidate hydrochloride, 95.0%, 250mg

Ethyl 6-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxylate, 97%, 5g

Methyl 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoate, 97%, 5g

3-cyanobenzamide, 95.0%, 5g

BOC-D-HIS(BOC)-OH, 97.0%, 1g

Methylimidazole, min 99%, for synthesis, 1L, glass packaging

2-(4-Fluoro-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

5-Oxo-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-6-carboxylic acid, 95.0%, 250mg

N-(2,2-Dimethoxyethyl)-2-phenylacetamide, 95.0%, 5g

5-Bromo-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid, 97%, 250mg

Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine, 97%, 1g